Skip to main content

Advertisement

Log in

Subcutaneous sarcoidosis: a clinical analysis of nine patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Subcutaneous sarcoidosis is the specific subset of cutaneous sarcoidosis frequently associated with systemic disease. However, the disease activity, severity, and prognosis have not yet been elucidated due to the limited number of reported cases. The purpose of this study was to identify the clinical, laboratory, and prognostic differences between subcutaneous sarcoidosis and other type of cutaneous sarcoidosis. All patients with sarcoidosis diagnosed histopathologically from 2000 to 2012 at our institution were enrolled. The clinical, laboratory, chest X-ray, and pulmonary function test results were retrospectively evaluated in the patients with cutaneous sarcoidosis. In the 130 patients with sarcoidosis, cutaneous sarcoidosis was diagnosed in 37 patients (28.4 %), and 9 (6.9 %) of these patients had subcutaneous sarcoidosis. The serum levels of soluble interleukin-2 receptor (sIL-2R) were significantly elevated in the group of patients with subcutaneous sarcoidosis in comparison to the patients with other types of cutaneous sarcoidosis, whereas there was no significant difference in the severity score between the two groups. Following a 2-year observation period, three patients were in remission, five patients demonstrated stable disease, and one patient had progressive disease. Subcutaneous sarcoidosis may be associated with the disease activity, although it was not found to be associated with the disease severity and it was not a predictive factor for the prognosis. Furthermore, the prevalence of subcutaneous sarcoidosis may be higher than that in previously reported series.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173

    CAS  PubMed  Google Scholar 

  2. Mana J, Marcoval J, Graells J, Salazar A, Peyri J, Pujol R (1997) Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 133:882–888

    Article  CAS  PubMed  Google Scholar 

  3. English JC 3rd, Patel PJ, Greer KE (2001) Sarcoidosis. J Am Acad Dermatol 44:725–743 quiz 744–726

    Article  PubMed  Google Scholar 

  4. Mana J, Marcoval J, Rubio M, Labori M, Fanlo M, Pujol R (2013) Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis 30:268–281

    PubMed  Google Scholar 

  5. Marcoval J, Mana J, Moreno A, Peyri J (2005) Subcutaneous sarcoidosis—clinicopathological study of 10 cases. Br J Dermatol 153:790–794

    Article  CAS  PubMed  Google Scholar 

  6. Costabel U, Hunninghake GW (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 14:735–737

    Article  CAS  PubMed  Google Scholar 

  7. Kalb RE, Epstein W, Grossman ME (1988) Sarcoidosis with subcutaneous nodules. Am J Med 85:731–736

    Article  CAS  PubMed  Google Scholar 

  8. Young RJ 3rd, Gilson RT, Yanase D, Elston DM (2001) Cutaneous sarcoidosis. Int J Dermatol 40:249–253

    Article  PubMed  Google Scholar 

  9. Elgart ML (1986) Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 4:35–45

    Article  CAS  PubMed  Google Scholar 

  10. Kieszko R, Krawczyk P, Jankowska O, Chocholska S, Krol A, Milanowski J (2007) The clinical significance of interleukin 18 assessment in sarcoidosis patients. Respir Med 101:722–728

    Article  PubMed  Google Scholar 

  11. Selroos OB (1986) Biochemical markers in sarcoidosis. Crit Rev Clin Lab Sci 24:185–216

    Article  CAS  PubMed  Google Scholar 

  12. Greene WC, Leonard WJ, Depper JM, Nelson DL, Waldmann TA (1986) The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Intern Med 105:560–572

    Article  CAS  PubMed  Google Scholar 

  13. Wolf RE, Brelsford WG (1988) Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 31:729–735

    Article  CAS  PubMed  Google Scholar 

  14. Brown AE, Rieder KT, Webster HK (1989) Prolonged elevations of soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis 139:1036–1038

    Article  CAS  PubMed  Google Scholar 

  15. Lawrence EC, Brousseau KP, Berger MB, Kurman CC, Marcon L, Nelson DL (1988) Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis 137:759–764

    Article  CAS  PubMed  Google Scholar 

  16. Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, Judson MA, Maier LA (2006) A new tool to assess sarcoidosis severity. Chest 129:1234–1245

    Article  PubMed  Google Scholar 

  17. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234

    Article  CAS  PubMed  Google Scholar 

  18. Ahmed I, Harshad SR (2006) Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol 54:55–60

    Article  PubMed  Google Scholar 

  19. Vainsencher D, Winkelmann RK (1984) Subcutaneous sarcoidosis. Arch Dermatol 120:1028–1031

    Article  CAS  PubMed  Google Scholar 

  20. Olive KE, Kataria YP (1985) Cutaneous manifestations of sarcoidosis. Relationships to other organ system involvement, abnormal laboratory measurements, and disease course. Arch Intern Med 145:1811–1814

    Article  CAS  PubMed  Google Scholar 

  21. Veien NK, Stahl D, Brodthagen H (1987) Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol 16:534–540

    Article  CAS  PubMed  Google Scholar 

  22. Marcoval J, Mana J, Rubio M (2011) Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol 36:739–744

    Article  CAS  PubMed  Google Scholar 

  23. Higgins EM, Salisbury JR, Du Vivier AW (1993) Subcutaneous sarcoidosis. Clin Exp Dermatol 18:65–66

    Article  CAS  PubMed  Google Scholar 

  24. Meyer-Gonzalez T, Suarez-Perez JA, Lopez-Navarro N, Hidalgo A, Herrera-Ceballos E (2011) Subcutaneous sarcoidosis: a predictor of systemic disease? Eur J Intern Med 22:e162–e163

    Article  PubMed  Google Scholar 

  25. Dalle Vedove C, Colato C, Girolomoni G (2011) Subcutaneous sarcoidosis: report of two cases and review of the literature. Clin Rheumatol 30:1123–1128

    Article  PubMed  Google Scholar 

  26. Keicho N, Kitamura K, Takaku F, Yotsumoto H (1990) Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. Chest 98:1125–1129

    Article  CAS  PubMed  Google Scholar 

  27. Mitchell DN, Scadding JG (1974) Sarcoidosis. Am Rev Respir Dis 110:774–802

    CAS  PubMed  Google Scholar 

  28. Gilman MJ, Wang KP (1980) Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 122:721–724

    Article  CAS  PubMed  Google Scholar 

  29. Hue SH (1987) Complications in transbronchial lung biopsy. Korean J Intern Med 2:209–213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor Tsuda T and Kumamoto T, MD, PhD, Department of Internal Medicine III and his team for performing broncofiberoscopy with BAL, and also Professor Fujiwara S, MD, PhD, Department of Dermatology and his team for performing skin biopsies and valuable assistance in the cutaneous histopathological records.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaru Ando.

Ethics declarations

This study was approved by the Institutional Ethics Committee approval of Oita University (no. 760).

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ando, M., Miyazaki, E., Hatano, Y. et al. Subcutaneous sarcoidosis: a clinical analysis of nine patients. Clin Rheumatol 35, 2277–2281 (2016). https://doi.org/10.1007/s10067-016-3356-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3356-0

Keywords

Navigation